ARISTOLOCHIC ACID (NSC-50413): PHASE I CLINICAL STUDY.
D000970:Antineoplastic Agents; D034341:Aristolochic Acids; D002648:Child; D004358:Drug Therapy; D009369:Neoplasms / Q000628:therapy*; D010616:Phenanthrenes; D012106:Research; D014116:Toxicology
D000970:Antineoplastic Agents; D034341:Aristolochic Acids; D010616:Phenanthrenes; C000228:aristolochic acid I
ANTINEOPLASTIC AGENTS; CHILD; DRUG THERAPY; NEOPLASM THERAPY; PHENANTHRENES; TOXICOLOGIC REPORT